FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.us.nhsn-ade
Resource TypeComposition
IdComposition-composition-ade-hypoglycemia-example-2.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative

Resource "composition-ade-hypoglycemia-example-2" Version "5" Updated "2021-09-02T22:43:43.233Z"

Information Source: #LKiV7reY1bMKRZBl!

Profile: Composition - ADE Hypoglycemia

identifier: id: 2eec4326-bf29-4428-8d02-a334a19cfc16

status: final

type: Adverse event note (LOINC#85893-6)

encounter: Encounter/encounter-completed-inpatient-ade-1

date: 2021-01-04T09:10:14Z

author: Practitioner/practitioner-ed-endocrinols-example: Dr. Ed Endocrinols " ENDOCRINOLS"

title: Adverse Event Note

confidentiality: N

Attesters

-ModeTimeParty
*legal2021-01-04T09:10:14ZPractitioner/practitioner-ed-endocrinols-example: Dr. Ed Endocrinols " ENDOCRINOLS"

custodian: Organization/organization-hospital-physician-group-example: Hospitalists of the World "Hospitalists of the World"


Source1

{
  "resourceType": "Composition",
  "id": "composition-ade-hypoglycemia-example-2",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2021-09-02T22:43:43.233+00:00",
    "source": "#LKiV7reY1bMKRZBl",
    "profile": [
      "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/Composition-ade-hypoglycemia"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "identifier": {
    "value": "2eec4326-bf29-4428-8d02-a334a19cfc16"
  },
  "status": "final",
  "type": {
    "coding": [
      {
        "system": "http://loinc.org",
        "code": "85893-6",
        "display": "Adverse event note"
      }
    ]
  },
  "subject": {
    "reference": "Patient/patient-ade-1",
    "display": "Name: 'masked'"
  },
  "encounter": {
    "reference": "Encounter/encounter-completed-inpatient-ade-1"
  },
  "date": "2021-01-04T09:10:14Z",
  "author": [
    {
      "reference": "Practitioner/practitioner-ed-endocrinols-example",
      "display": "Dr. Ed Endocrinols"
    }
  ],
  "title": "Adverse Event Note",
  "confidentiality": "N",
  "attester": [
    {
      "mode": "legal",
      "time": "2021-01-04T09:10:14Z",
      "party": {
        "reference": "Practitioner/practitioner-ed-endocrinols-example",
        "display": "Dr. Ed Endocrinols"
      }
    }
  ],
  "custodian": {
    "reference": "Organization/organization-hospital-physician-group-example",
    "display": "Hospitalists of the World"
  },
  "section": [
    {
      "title": "Results Section",
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "30954-2",
            "display": "Relevant diagnostic tests/laboratory data Narrative"
          }
        ]
      },
      "entry": [
        {
          "reference": "Observation/observation-lab-ade",
          "display": "Observation: Lab Test - Glucose [Moles/volume] in Serum or Plasma --1 hour post meal"
        }
      ]
    },
    {
      "title": "Medication Section",
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10160-0",
            "display": "History of Medication use Narrative"
          }
        ]
      },
      "entry": [
        {
          "reference": "MedicationAdministration/medicationadministration-metformin-er",
          "display": "MedicationAdminstration: 24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"
        }
      ]
    }
  ]
}